Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2018 Jul 17;356:36–43. doi: 10.1016/j.taap.2018.07.017

Fig. 4.

Fig. 4.

Effect of treatment with FPN siRNA on FPN levels and on Cd and iron accumulation. The cells were transiently transfected with either control or FPN siRNA for 2 days and then treated with 3 μΜ Cd for 24 h. (A) Suppression of FPN expression by the FPN siRNA. (B and C) Cellular Cd and iron concentrations measured by ICP-MS. Results are expressed as mean±SE (n = 6). *Significantly different from the respective control.#Significantly different from the cells treated with control siRNA. (p < 0.05).